Volume 5, Issue 4

• Medication Adherence and Subjective Weight Perception in Patients with First-Episode Psychotic Disorder
  Author(s): Mimi MC Wong, , EYH Chen, , Simon SY Lui, Steve Tso
  • Abstract
  • PDF
• Staccato Loxapine Resubmitted to FDA
  Author(s): Peter F. Buckley
  • Abstract
  • PDF
• Infection-Associated Clozapine Toxicity
  Author(s): Pam Darling, Mark Arthur Huthwaite
  • Abstract
  • PDF
• Psychosis Risk Syndrome and DSM-5: Time for a Dimensional Approach to At-Risk Mental States?
  Author(s): Andrea Raballo, Frank Larøi
  • Abstract
  • PDF
• The Comorbidity of Psychotic Symptoms and Posttraumatic Stress Disorder: Evidence for a Specifier in DSM-5
  Author(s): Julia Vigna Bosson, , Erin T. Reuther, , Alex S. Cohen
  • Abstract
  • PDF
• Antipsychotics and Physical Attractiveness
  Author(s): Mary V. Seeman
  • Abstract
  • PDF
• Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study
  Author(s): Miranda Chakos , Javendra K. Patel , Robert Rosenheck , Ira D. Glick , Mark B. Hamner , Del D. Miller , Andre Tapp , Alexander Miller
  • Abstract